ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,629Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 3035

$1.44M Total Retail Price of All Prescriptions

Rank: 132 out of 3035

541 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

28% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 897 875 83 1 27
AMLODIPINE BESYLATE 785 703 118 2 2
ATORVASTATIN CALCIUM 740 649 106 3 6
LISINOPRIL 736 643 131 4 3
HYDROCODONE-ACETAMINOPHEN 730 608 151 S3 5 5
FUROSEMIDE 716 593 119 6 7
LEVOTHYROXINE SODIUM 703 628 110 7 1
SIMVASTATIN 605 524 107 8 4
QUETIAPINE FUMARATE 489 390 65 A 9 53
TRAMADOL HCL 485 446 95 10 17
DONEPEZIL HCL 474 440 83 11 31
MIRTAZAPINE 466 431 83 12 62
POTASSIUM CHLORIDE 458 358 72 13 15
CITALOPRAM HBR 432 356 67 14 29
METOPROLOL TARTRATE 408 334 68 15 10
CARVEDILOL 357 282 58 16 21
CLOPIDOGREL 349 330 51 17 18
OMEPRAZOLE 327 274 69 18 8
METFORMIN HCL 323 288 54 19 9
DIVALPROEX SODIUM 318 258 51 20 110
RANITIDINE HCL 309 258 40 21 64
LOSARTAN POTASSIUM 282 243 46 22 14
TRAZODONE HCL 281 256 57 23 40
TAMSULOSIN HCL 279 233 45 24 28
SERTRALINE HCL 276 220 45 25 26
GABAPENTIN 272 247 42 26 12
NEXIUM 266 220 31 27 20
METOPROLOL SUCCINATE 253 210 41 28 13
WARFARIN SODIUM 241 236* 21 29 25
LEVETIRACETAM 235 150 26 30 99
ESCITALOPRAM OXALATE 225 196 30 31 42
CLONIDINE HCL 223 181 50 32 48
NOVOLIN R 220 180 40 33 139
RISPERIDONE 215 197 36 A 34 83
DIOVAN 214 188 19 35 36
LORAZEPAM 206 167 74 B 36 47
HYDRALAZINE HCL 203 144 36 37 59
LANTUS 190 147 32 38 56
ABILIFY 189 123 19 A 39 128
METOCLOPRAMIDE HCL 184 127 27 40 130
PRAVASTATIN SODIUM 176 155 32 41 11
MELOXICAM 172 167* 36 42 35
FAMOTIDINE* 162 122 27 43 76
HYDROCHLOROTHIAZIDE 161 143 25 44 16
CLONAZEPAM 152 108 26 B 45 58
CYMBALTA 150 125 18 46 39
FINASTERIDE 147 142* 26 47 90
PANTOPRAZOLE SODIUM 143 128 30 48 24
FLUTICASONE PROPIONATE 136 124 45 49 33
OXYBUTYNIN CHLORIDE 129 109 19 50 131
ALPRAZOLAM 117 87 28 B 51 19
ALENDRONATE SODIUM 117 112* 22 51 30
JANUVIA 113 108* 13 53 49
BACLOFEN 113 91 17 53 107
FENOFIBRATE* 110 81 12 55 57
PHENYTOIN SODIUM EXTENDED 105 83 16 56 146
CRESTOR 105 82 18 56 22
ATENOLOL 104 99* 20 58 32
DIVALPROEX SODIUM ER 103 73 23 59 185
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 91 51 60 88
GLIMEPIRIDE 101 81 15 61 37
NIFEDIPINE ER 100 85 16 62 75
FLUOXETINE HCL 98 71 14 63 77
MONTELUKAST SODIUM 96 96 23 64 44
NUEDEXTA 94 <11 <11 65 231
LIDODERM 93 88* 18 66 125
TRAVATAN Z 91 86* 17 67 284
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 79 13 67 34
POLYETHYLENE GLYCOL 3350 91 73 24 67 97
OLANZAPINE 87 62 16 A 70 138
ALLOPURINOL 87 65 18 70 38
LOVAZA 87 <11 <11 70 95
INSULIN SYRINGE* 87 66 16 70 186
SANTYL 86 73 27 74 215
PREMARIN 85 80* 11 R 75 123
CIPROFLOXACIN HCL 84 68 61 76 51
SPIRONOLACTONE 83 56 16 77 69
CARBIDOPA-LEVODOPA 81 81 12 78 129
NYSTATIN 81 67 38 78 164
EXELON 80 75* 14 80 98
HUMULIN R 79 74* 25 81 228
IPRATROPIUM-ALBUTEROL 78 32 29 82 140
LABETALOL HCL 75 <11 <11 83 170
SPIRIVA 75 61 19 83 78
PREDNISONE 75 64 25 83 45
DOXAZOSIN MESYLATE 75 70* 16 83 94
LEVOFLOXACIN 75 70* 57 83 55
DIGOX 72 72 15 88 100
BENZTROPINE MESYLATE 72 <11 <11 R 88 203
KLOR-CON M20 72 50 20 88 93
PIOGLITAZONE HCL 70 65* 12 R 91 86
LEVEMIR 70 44 12 91 133
PROMETHAZINE HCL 69 64* 41 R 93 116
LACTULOSE 68 55 19 94 114
AMLODIPINE BESYLATE-BENAZEPRIL 66 61* 11 95 71
VESICARE 65 <11 <11 96 108
LANTUS SOLOSTAR 65 <11 <11 96 73
TRANSDERM-SCOP 65 32 12 96 373
ENALAPRIL MALEATE 62 <11 <11 99 60
GLIPIZIDE 62 <11 <11 99 50
NOVOLIN 70-30 62 <11 <11 99 165
LATANOPROST 61 47 15 102 193
CYCLOBENZAPRINE HCL 61 56* 13 R 102 79
HUMALOG 58 <11 <11 104 150
NOVOLOG 58 47 12 104 127
LOSARTAN-HYDROCHLOROTHIAZIDE 58 <11 <11 104 43
CELEBREX 57 <11 <11 107 74
ADVAIR DISKUS 56 51* 16 108 66
TRIAMTERENE-HCTZ 56 <11 <11 108 68
PHENYTOIN 54 <11 <11 110 256
ARICEPT 54 <11 <11 110 404
NAPROXEN 53 34 19 112 84
ISOSORBIDE DINITRATE 53 <11 <11 112 318
GLYBURIDE 52 47* 12 R 114 89
ZOLPIDEM TARTRATE 51 46* 13 115 23
BUSPIRONE HCL 51 51 12 115 142
DETROL LA 50 <11 <11 117 175
ZIPRASIDONE HCL 50 <11 <11 A 117 300
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.